Literature DB >> 16869367

Obsessive compulsive disorder treatment in patients with Down syndrome: a case series.

Bruce Sutor1, Mark R Hansen, John L Black.   

Abstract

In this case series we report four cases of patients with Down syndrome with symptoms consistent with obsessive compulsive disorder. Each patient experienced substantial reduction in compulsive behaviors with pharmacotherapy of an SSRI alone or with the addition of risperidone to SSRI therapy. None of the patients experienced significant side effects. This small case series supports the use of these medications in the treatment of co-morbid obsessive compulsive disorder in patients with Down syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16869367     DOI: 10.3104/case-studies.299

Source DB:  PubMed          Journal:  Downs Syndr Res Pract        ISSN: 0968-7912


  3 in total

Review 1.  Pharmacotherapeutic Considerations for Individuals with Down Syndrome.

Authors:  Erik Hefti; Javier G Blanco
Journal:  Pharmacotherapy       Date:  2017-01-13       Impact factor: 4.705

2.  Psychological Support for Young Adults with Down Syndrome: Dohsa-Hou Program for Maladaptive Behaviors and Internalizing Problems.

Authors:  Haruo Fujino
Journal:  Front Psychol       Date:  2017-09-01

3.  Obsessive compulsive disorder comorbidity in DBA.

Authors:  Stefano Pallanti; Sara Masetti; Silvia Bernardi; Alice Innocenti; Mariana Markella; Eric Hollander
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.